Omron, InterCure jointly address UK hypertension market:
This article was originally published in Clinica
Executive Summary
Omron Healthcare, a UK-based subsidiary of Japanese sensing technology specialist, is teaming up with InterCure, the New York, US-based developer of the RESPeRATE device for lowering blood pressure, in a co-marketing effort aimed at the UK hypertension market. As part of the agreement, Omron will include product information about RESPeRATE in boxes of its M10i blood pressure monitors, while InterCure will provide information on Omron's product in its RESPeRATE packaging.
You may also be interested in...
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.